View in EDS

Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma.

Saved in:
Bibliographic Details
Title: Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma.
Authors: Liebers N; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Boumendil A; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Finel H; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Edelmann D; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Baermann BN; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Serroukh Y; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Blaise D; Institut Paoli Calmettes, Marseille, France., Beelen DW; University Hospital Essen, Essen, Germany., Solano C; Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Itälä-Remes M; University Hospital Turku, Turku, Finland., van Meerten T; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Choi G; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schmidt SAC; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Kröger N; University Medical Center Hamburg, Hamburg, Germany., Byrne J; Nottingham University, Nottingham, United Kingdom., Tudesq JJ; CHU Lapeyronie, Montpellier, France., Ossami Saidy A; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Nunes A; Kite, a Gilead Company, Santa Monica, California., Siddiqi R; Kite, a Gilead Company, Santa Monica, California., Baro E; Kite, a Gilead Company, Santa Monica, California., Zheng D; Kite, a Gilead Company, Santa Monica, California., Kloos I; Kite, a Gilead Company, Santa Monica, California., Dreger P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Sureda A; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Clinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Glass B; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Dietrich S; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.
Source: Blood cancer discovery [Blood Cancer Discov] 2025 May 05; Vol. 6 (3), pp. 182-190.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39913291
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liebers+N%22">Liebers N</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Boumendil+A%22">Boumendil A</searchLink>; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Finel+H%22">Finel H</searchLink>; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Edelmann+D%22">Edelmann D</searchLink>; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kobbe+G%22">Kobbe G</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Baermann+BN%22">Baermann BN</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Serroukh+Y%22">Serroukh Y</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Blaise+D%22">Blaise D</searchLink>; Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Beelen+DW%22">Beelen DW</searchLink>; University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Solano+C%22">Solano C</searchLink>; Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Itälä-Remes+M%22">Itälä-Remes M</searchLink>; University Hospital Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22van+Meerten+T%22">van Meerten T</searchLink>; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Choi+G%22">Choi G</searchLink>; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schmidt+SAC%22">Schmidt SAC</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Kröger+N%22">Kröger N</searchLink>; University Medical Center Hamburg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Byrne+J%22">Byrne J</searchLink>; Nottingham University, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tudesq+JJ%22">Tudesq JJ</searchLink>; CHU Lapeyronie, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Ossami+Saidy+A%22">Ossami Saidy A</searchLink>; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Nunes+A%22">Nunes A</searchLink>; Kite, a Gilead Company, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Siddiqi+R%22">Siddiqi R</searchLink>; Kite, a Gilead Company, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Baro+E%22">Baro E</searchLink>; Kite, a Gilead Company, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Zheng+D%22">Zheng D</searchLink>; Kite, a Gilead Company, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Kloos+I%22">Kloos I</searchLink>; Kite, a Gilead Company, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Dreger+P%22">Dreger P</searchLink>; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sureda+A%22">Sureda A</searchLink>; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Clinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Glass+B%22">Glass B</searchLink>; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Dietrich+S%22">Dietrich S</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2025 May 05; Vol. 6 (3), pp. 182-190.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39913291
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2643-3230.BCD-24-0178
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 182
    Titles:
      – TitleFull: Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liebers N
      – PersonEntity:
          Name:
            NameFull: Boumendil A
      – PersonEntity:
          Name:
            NameFull: Finel H
      – PersonEntity:
          Name:
            NameFull: Edelmann D
      – PersonEntity:
          Name:
            NameFull: Kobbe G
      – PersonEntity:
          Name:
            NameFull: Baermann BN
      – PersonEntity:
          Name:
            NameFull: Serroukh Y
      – PersonEntity:
          Name:
            NameFull: Blaise D
      – PersonEntity:
          Name:
            NameFull: Beelen DW
      – PersonEntity:
          Name:
            NameFull: Solano C
      – PersonEntity:
          Name:
            NameFull: Itälä-Remes M
      – PersonEntity:
          Name:
            NameFull: van Meerten T
      – PersonEntity:
          Name:
            NameFull: Choi G
      – PersonEntity:
          Name:
            NameFull: Schmidt SAC
      – PersonEntity:
          Name:
            NameFull: Kröger N
      – PersonEntity:
          Name:
            NameFull: Byrne J
      – PersonEntity:
          Name:
            NameFull: Tudesq JJ
      – PersonEntity:
          Name:
            NameFull: Ossami Saidy A
      – PersonEntity:
          Name:
            NameFull: Nunes A
      – PersonEntity:
          Name:
            NameFull: Siddiqi R
      – PersonEntity:
          Name:
            NameFull: Baro E
      – PersonEntity:
          Name:
            NameFull: Zheng D
      – PersonEntity:
          Name:
            NameFull: Kloos I
      – PersonEntity:
          Name:
            NameFull: Dreger P
      – PersonEntity:
          Name:
            NameFull: Sureda A
      – PersonEntity:
          Name:
            NameFull: Glass B
      – PersonEntity:
          Name:
            NameFull: Dietrich S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 05
              Text: 2025 May 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2643-3249
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Blood cancer discovery
              Type: main
ResultId 1